Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.
about
Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and ProgressionTargeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer.Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.Androgen receptor activation: a prospective therapeutic target for bladder cancer?Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.TR4 nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression.
P2860
Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Antiandrogen Therapy with Hydr ...... ss Bladder Cancer Progression.
@ast
Antiandrogen Therapy with Hydr ...... ss Bladder Cancer Progression.
@en
type
label
Antiandrogen Therapy with Hydr ...... ss Bladder Cancer Progression.
@ast
Antiandrogen Therapy with Hydr ...... ss Bladder Cancer Progression.
@en
prefLabel
Antiandrogen Therapy with Hydr ...... ss Bladder Cancer Progression.
@ast
Antiandrogen Therapy with Hydr ...... ss Bladder Cancer Progression.
@en
P2093
P2860
P1476
Antiandrogen Therapy with Hydr ...... ss Bladder Cancer Progression.
@en
P2093
Chawnshang Chang
Chih-Rong Shyr
Edward Messing
Minghao Zhang
Shuyuan Yeh
Yuanjie Niu
Zhiqun Shang
P2860
P304
P356
10.1158/1535-7163.MCT-14-1055-T
P577
2015-08-11T00:00:00Z